Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as induction and maintenance therapy for CMV retinitis

Journal of Infectious Diseases

Volumn 184, Issue 12, 2001, Pages 1598-1602

  Boivin, Guy ^a   Gilbert, Christian ^a   Gaudreau, Annie ^a   Greenfield, Isobel ^b   Sudlow, Rebecca ^b   Roberts, Noel A ^b  

^a UNIVERSITÉ LAVAL   (Canada)

^b ROCHE PRODUCTS LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; VALGANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS; EVALUATION; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LEUKOCYTE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETINITIS; SEQUENCE ANALYSIS; VIRUS MUTATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS RETINITIS; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE, VIRAL; GANCICLOVIR; HUMANS; LEUKOCYTES; MUTATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); VIRAL PROTEINS;

EID: 0035892802     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/324672     Document Type: Article

References (15)

1. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection
2. Cytomegalovirus retinitis and viral resistance: Ganciclovir resistance
3. Emergence and prevalence of cytomegalovirus UL97 mutations associated with ganciclovir resistance in AIDS patients
4. Detection of ganciclovir resistance mutations and quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease
5. Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS
6. A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives
7. A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance
8. Resistance of human cytomegalovirus to antiviral drugs
9. Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients
10. High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes
11. Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance
12. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates
13. The dynamics of human cytomegalovirus replication in vivo
14. Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments
15. Mutations in the cytomegalovirus UL97 gene associated with ganciclovir-resistant retinitis